NO166486C - Analogifremgangsmaate for fremstilling av et terapeutisk aktivt peptid. - Google Patents

Analogifremgangsmaate for fremstilling av et terapeutisk aktivt peptid.

Info

Publication number
NO166486C
NO166486C NO832148A NO832148A NO166486C NO 166486 C NO166486 C NO 166486C NO 832148 A NO832148 A NO 832148A NO 832148 A NO832148 A NO 832148A NO 166486 C NO166486 C NO 166486C
Authority
NO
Norway
Prior art keywords
peptid
preparing
therapeutic active
analogue procedure
analogue
Prior art date
Application number
NO832148A
Other languages
English (en)
Norwegian (no)
Other versions
NO166486B (no
NO832148L (no
Inventor
Nicholas Chai-Kwan Ling
Frederick Stephen Esch
Peter Bohlen
Paul Ernest Brazeau Jr
Roger Charles Louis Guillemin
Original Assignee
Salk Inst For Biological Studi
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US06/418,248 external-priority patent/US4517181A/en
Application filed by Salk Inst For Biological Studi filed Critical Salk Inst For Biological Studi
Publication of NO832148L publication Critical patent/NO832148L/no
Publication of NO166486B publication Critical patent/NO166486B/no
Publication of NO166486C publication Critical patent/NO166486C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/60—Growth hormone-releasing factor [GH-RF], i.e. somatoliberin
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/142—Amino acids; Derivatives thereof
    • A23K20/147—Polymeric derivatives, e.g. peptides or proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/12—Growth hormone, growth factor other than t-cell or b-cell growth factor, and growth hormone releasing factor; related peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Endocrinology (AREA)
  • Polymers & Plastics (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Animal Husbandry (AREA)
  • Food Science & Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Diabetes (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
NO832148A 1982-06-16 1983-06-14 Analogifremgangsmaate for fremstilling av et terapeutisk aktivt peptid. NO166486C (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US8200812 1982-06-16
US06/418,248 US4517181A (en) 1982-09-15 1982-09-15 Mammalian PGRF

Publications (3)

Publication Number Publication Date
NO832148L NO832148L (no) 1983-12-19
NO166486B NO166486B (no) 1991-04-22
NO166486C true NO166486C (no) 1991-07-31

Family

ID=26766557

Family Applications (1)

Application Number Title Priority Date Filing Date
NO832148A NO166486C (no) 1982-06-16 1983-06-14 Analogifremgangsmaate for fremstilling av et terapeutisk aktivt peptid.

Country Status (14)

Country Link
EP (1) EP0107890B1 (de)
KR (1) KR900006711B1 (de)
AU (1) AU548590B2 (de)
CA (1) CA1247599A (de)
DD (1) DD217808A5 (de)
ES (1) ES523277A0 (de)
FI (1) FI79716C (de)
GR (1) GR78614B (de)
IL (1) IL68893A0 (de)
NO (1) NO166486C (de)
NZ (1) NZ204456A (de)
PH (1) PH21001A (de)
PT (1) PT76843B (de)
SU (1) SU1531857A3 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4518586A (en) * 1983-01-13 1985-05-21 The Salk Institute For Biological Studies GRF Analogs III
US4581168A (en) * 1983-02-21 1986-04-08 Sanofi Synthesis of hpGRF (Somatocrinin) in liquid phase and intermediate peptides
AU575843B2 (en) * 1983-08-10 1988-08-11 The Administrators Of The Tulane Eductional Fund Growth hormone releasing peptides
PT79094B (en) * 1983-08-29 1986-08-14 Salk Inst For Biological Studi Grf analogs
FR2567524B1 (fr) * 1984-07-10 1987-11-27 Sanofi Sa Procede de synthese de la somatocrinine en phase liquide et peptides intermediaires
CA1271600A (en) * 1985-01-07 1990-07-10 David Howard Coy Growth hormone-releasing peptides and method of treating mammals therewith
FR2599038B1 (fr) * 1986-05-26 1990-06-29 Sanofi Sa Procede de preparation de nonacosapeptides et peptides intermediaires

Also Published As

Publication number Publication date
PT76843B (en) 1986-01-15
DD217808A5 (de) 1985-01-23
NZ204456A (en) 1987-05-29
EP0107890A1 (de) 1984-05-09
KR840006328A (ko) 1984-11-29
FI832176L (fi) 1983-12-17
FI79716B (fi) 1989-10-31
FI832176A0 (fi) 1983-06-15
CA1247599A (en) 1988-12-28
KR900006711B1 (ko) 1990-09-17
IL68893A0 (en) 1983-10-31
EP0107890B1 (de) 1986-01-29
PT76843A (en) 1983-07-01
ES8504673A1 (es) 1985-04-16
NO166486B (no) 1991-04-22
NO832148L (no) 1983-12-19
AU548590B2 (en) 1985-12-19
FI79716C (fi) 1990-02-12
ES523277A0 (es) 1985-04-16
SU1531857A3 (ru) 1989-12-23
GR78614B (de) 1984-09-27
PH21001A (en) 1987-06-22
AU1584383A (en) 1983-12-22

Similar Documents

Publication Publication Date Title
NO161002C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive polypeptider.
NO160850C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive n-(bicykliske heterocyklyl)-4-piperidinaminer.
NO164025C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 3-imidazolylmetyl-tetrahydrokarbazolon-derivater.
NO156785B (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive cyklobutan-derivater.
NO150760C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive aminotiazoler.
NO163285C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive steroider.
NO161497C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 9a-aza-9a-homoerytromycin-derivater.
NO158460C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive forbindelser.
NO164541C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive benzimidazolderivater.
NO167797C (no) Analogifremgangsmaate for fremstilling av et terapeutisk aktivt nitrometan.
NO162817C (no) Analogifremgangsmaate for fremstilling av terapeutisk virksomme 4-aryl-4-piperidin-carbinoler.
NO870866L (no) Fremgangsmÿte for fremstilling av et terapeutisk kombinasjonspreparat.
NO166486C (no) Analogifremgangsmaate for fremstilling av et terapeutisk aktivt peptid.
NO159090C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive pyridoindol-derivater.
NO158800C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive indenderivater.
NO156167C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive indolinon-derivater.
NO163570C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive acylaminomitosaner.
NO162188C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive imidazokinoliner.
NO875461D0 (no) Fremgangsmaate for fremstilling av et terapeutisk aktivt peptid.
JPS54141797A (en) Therapeutic drug
NO152843C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive pyrimidopyrimidiner.
NO155842C (no) Analogifremgangsmaate ved fremstilling av terapeutiske aktive 2-beta-d-ribofuranosylselenazol-4-carboxamider.
NO163617C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive pyrrolidinon-derivater.
NO164246C (no) Analogifremgangsmaate for fremstilling av et terapeutisk aktivt antigent peptid.
NO164973C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive gem-dihalo- og tetrahalo-1,2-diamino-4,9,-diaza-dodecaner.

Legal Events

Date Code Title Description
MK1K Patent expired

Free format text: EXPIRED IN JUNE 2003